The rising incidence and mortality of prostate cancer in belgrade population;Rastuča incidencija i smrtnost od raka prostate u populaciji grada beograda

Collegium Antropologicum

Volumn 35, Issue 2, 2011, Pages 499-503

  Janković, Janko ^a   Šipetić, Sandra ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Belgrade; Incidence; Mortality; Prostate cancer; Trend

Indexed keywords

AGED; ARTICLE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PROSTATE TUMOR; REGRESSION ANALYSIS; SERBIA;

AGED; AGED, 80 AND OVER; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; SERBIA;

EID: 79959764787     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. GARCIA M, JEMAL A, WARD EM, CENTER MM, HAO Y, SIEGEL RL, THUN MJ, Global Cancer Facts & Figures 2007. (American Cancer Society, Atlanta, 2007). Accessed 27.07.2010. Available from: URL: http://cancer.org/acs/groups/content/@nho/documents/document/globalfactsandfigures2007rev2p.pdf.
2. SIGNORELLO LB, ADAMI HO, Prostate Cancer. In: ADAMI HO, HUNTER D, TRICHOPOULOS D (Eds) Textbook of Cancer Epidemiology (Oxford University Press, New York, 2002).
3. PLATZ EA, GIOVANNUCCI E, Prostate cancer. In: SCHOTTENFELD D, FRAUMENI JF (Eds) Cancer Epidemiology and Prevention, (Oxford University Press, New York, 2006).
4. FERLAY J, SHIN HR, BRAY F, FORMAN D, MATHERS C, PARKIN DM, GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide, IARC CancerBase No. 10 [Internet], Lyon, France: International Agency for Research on Cancer, 2010. Accessed 27. 07.2010. Available from: URL: http://globocan.iarc.fr.
5. HSING AW, DEVESA SS, Epidemiol Rev, 23 (2001) 3.
6. AHMAD OB, BOSCHI-PINTO C, LOPEZ A, MURRAY CJL, LOZANO R, INOUE M, Age Standardization of Rates: A New WHO Standard, Global Programme on Evidence for Health Policy Discussion Paper Series: No. 31. (WHO, Geneva, 2000).
7. STATISTICAL RESEARCH AND APPLICATIONS. NATIONAL CANCER INSTITUTE. Joinpoint Regression Program, Version 3.4.2. Accessed 27.07.2010. Available from: URL: http://srab.cancer.gov/joinpoint/.
8. KIM HJ, FAY MP, FEUER EJ, MIDTHUNE DN, Stat Med, 19 (2000) 335.
9. KIM HJ, FAY MP, FEUER EJ, MIDTHUNE DN, Correction: 20 (2001) 655.
10. QUINN M, BABB P, BJU Int, 90 (2002) 174.
11. QUINN M, BABB P, BJU Int, 90 (2002) 162.
12. FERLAY J, BRAY F, PISANI P, PARKIN DM, Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide, IARC CancerBase No. 5, Version 2.0. (International Agency for Research on Cancer Press, Lyon, 2004).
13. GILES GG, THURSFIELD V (Eds) Prostate Cancer. Canstat 30 (Anti-Cancer Council of Victoria, Carlton, Australia, 2000).
14. BRASSO K, FRIIS S, KRUGER KJÆR S, JORGENSEN T, IVERSEN P, Urology, 51 (1998) 590.
15. SCHUZ J, SCHON D, BATZLER W, BAUMGARDT-ELMS C, EISINGER B, LEHNERT M, STEGMAIER C, J Epidemiol Biostat, 5 (2000) 99.
16. POST PN, KIL PJM, CROMMELIN MA, SCHAPERS RFM, COEBERGH JWW, Eur J Cancer, 34 (1998) 705.
17. HELGESEN F, HOLMBERG L, JOHANSSON JE, BERGSTROM R, ADAMI HO, J Natl Cancer Inst, 88 (1996) 1216.
18. LEVY IG, GIBBONS L, COLLINS JP, PERKINS DG, MAO Y, Can Med Assoc J, 149 (1993) 617.
19. POTOSKY AL, KESSLER L, GRIDLEY G, BROWN CC, HORN JW, J Natl Cancer Inst, 82 (1990) 1624.
20. POST PN, DAMHUIS RAM, VAN DER MEYDEN APM, THE EUROCARE WORKING GROUP, Eur J Cancer, 34 (1998) 2226.
21. POTOSKY AL, MILLER BA, ALBERTSEN PC, KRAMER BS, J Am Med Assoc, 273 (1995) 548.
22. MCDAVID K, LEE J, FULTON JP, TONITA J, THOMPSON TD, J Public Health Rep, 119 (2004) 174.
23. LEGLER JM, FEUER EJ, POTOSKY AL, MERRILL RM, KRAMER BS, Cancer Causes Control, 9 (1998) 519.
24. LEVY I, Can J Oncol, 4 (1994) 4.
25. MAJEED A, BABB PJ, JONES J, QUINN M, BJU Int, 85 (2000) 1.
26. AMERICAN CANCER SOCIETY, The Worldwide Cancer Burden. (American cancer society, Atlanta, 2006).
27. OLIVER SE, MAY MT, GUNNELL D, Int J Cancer, 92 (2001) 893.
28. CAYUELA A, RODRIGUEZ-DOMINGUEZ S, MARTIN VE, CANDAU BR, Actas Urol Esp, 32 (2008) 184.
29. VIVES A, VALDIVIA G, MARSHALL G, Rev med Chil, 132 (2004) 579.
30. AGALLIU I, WEISS NS, LIN DW, STANFORD JL, Cancer Causes Control, 18 (2007) 931.
31. SANDBLOM G, VARENHORST E, LÖFMAN O, ROSELL J, CARLSSON P, Eur Urol, 46 (2004) 717.
32. BOUCHARDY C, FIORETTA G, RAPITI E, VERKOOIJEN HM, RAPIN CH, SCHMIDLIN F, MIRALBELL R, ZANETTI R, Int J Cancer, 123 (2008) 421.
33. VUKOTIĆ-MALETIĆ V, CEROVIĆ S, LAZIĆ M, RAKOVIĆ I, J BUON, 10 (2005) 265.
34. POLASEK O, KOLCIC I, VONCINA L, STRNAD M, VULETIC S, KERN J, Rural Remote Health, 7 (2007) 749.
35. ANDRIOLE GL, CRAWFORD ED, GRUBB RL 3RD, BUYS SS, CHIA D, CHURCH TR, FOUAD MN, GELMANN EP, KVALE PA, REDING DJ, WEISSFELD JL, YOKOCHI LA, O'BRIEN B, CLAPP JD, RATHMELL JM, RILEY TL, HAYES RB, KRAMER BS, IZMIRLIAN G, MILLER AB, PINSKY PF, PROROK PC, GOHAGAN JK, BERG CD; PLCO PROJECT TEAM, N Engl J Med 360 (2009) 1310.
36. SCHRÖDER FH, HUGOSSON J, ROOBOL MJ, TAMMELA TL, CIATTO S, NELEN V, KWIATKOWSKI M, LUJAN M, LILJA H, ZAPPA M, DENIS LJ, RECKER F, BERENGUER A, MÄÄTTÄNEN L, BANGMA CH, AUS G, VILLERS A, REBILLARD X, VAN DER KWAST T, BLIJENBERG BG, MOSS SM, DE KONING HJ, AUVINEN A; ERSPC NVESTIGATORS, N Engl JMed, 360 (2009) 1320.